Cannabis Medicine, Patients & Business in Brazil

Watch insights from our Cannabis in Brazil: The Development of the Largest Market in Latin America discussion at GCI Virtual Summit (June 2021).

Analysing patient access to cannabis medicine and business opportunities for domestic and overseas players alike, we were joined by Dr. Paula Dall’Stella from the Brazilian Association of Medicinal Cannabis Patients; Ivo Bucaresky, Former ANVISA; Viviane Sedola from Dr. Cannabis; and Dr. Carolina Nocetti from Intercan Brazil.

To meet, network and collaborate with global cannabis and psychedelic leaders, check out the GCI Summit.

To explore additional cannabis content, click here.

Previous articleCould Ketamine Treat Parkinson’s Disease? Clinical Trial Says Yes
Next articleProfessionally Cannabis Podcast – Nancy Whiteman, Wana Brands